CLP-1 associates with MyoD and HDAC to restore skeletal muscle cell regeneration

• Published in: Journal of cell science Vol. 123; no. Pt 21; pp. 3789 - 3795
• Main Authors: Galatioto, Josephine, Mascareno, Eduardo, Siddiqui, M A Q
• Format: Journal Article
• Language: English
• Published: England Company of Biologists 01.11.2010
• Subjects: Animals; Cell Differentiation; Cell Line; Gene Expression Regulation, Developmental - genetics; Genes, bcl-1 - genetics; Histone Deacetylases - metabolism; Mice; Muscle, Skeletal - pathology; Myoblasts, Skeletal - metabolism; Myoblasts, Skeletal - pathology; MyoD Protein - metabolism; Positive Transcriptional Elongation Factor B - metabolism; Protein Binding - genetics; RNA, Small Interfering - genetics; Transcription Factors - genetics; Transcription Factors - metabolism; Transcriptional Activation - genetics
• ISSN: 0021-9533; 1477-9137
• DOI: 10.1242/jcs.073387

Emerging evidence suggests that eukaryotic gene transcription is regulated primarily at the elongation stage by association and dissociation of the inhibitory protein cardiac lineage protein 1 (CLP-1/HEXIM1) from the positive transcription elongation factor b (P-TEFb) complex. It was reported recently that P-TEFb interacts with skeletal muscle-specific regulatory factor, MyoD, suggesting a linkage between CLP-1-mediated control of transcription and skeletal myogenesis. To examine this, we produced CLP-1 knockdown skeletal muscle C2C12 cells by homologous recombination, and demonstrated that the C2C12 CLP-1 +/- cells failed to differentiate when challenged by low serum in the medium. We also showed that CLP-1 interacts with both MyoD and histone deacetylases (HDACs) maximally at the early stage of differentiation of C2C12 cells. This led us to hypothesize that the association might be crucial to inhibition of MyoD-target proliferative genes. Chromatin immunoprecipitation analysis revealed that the CLP-1/MyoD/HDAC complex binds to the promoter of the cyclin D1 gene, which is downregulated in differentiated muscle cells. These findings suggest a novel transcriptional paradigm whereby CLP-1, in conjunction with MyoD and HDAC, acts to inhibit growth-related gene expression, a requirement for myoblasts to exit the cell cycle and transit to myotubes.